Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

“Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway
Emira Bousoik, Hamidreza Montazeri Aliabadi
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 336

Showing 26-50 of 336 citing articles:

Role of the JAK/STAT Pathway in Cervical Cancer: Its Relationship with HPV E6/E7 Oncoproteins
Adriana Gutiérrez‐Hoya, Isabel Soto‐Cruz
Cells (2020) Vol. 9, Iss. 10, pp. 2297-2297
Open Access | Times Cited: 108
Thyroid and COVID-19: a review on pathophysiological, clinical and organizational aspects
Giuseppe Lisco, Anna De Tullio, Emilio Jirillo, et al.
Journal of Endocrinological Investigation (2021) Vol. 44, Iss. 9, pp. 1801-1814
Open Access | Times Cited: 100
The bio-mission of interleukin-6 in the pathogenesis of COVID-19: A brief look at potential therapeutic tactics
Mitra Abbasifard, Hossein Khorramdelazad
Life Sciences (2020) Vol. 257, pp. 118097-118097
Open Access | Times Cited: 89
Potential therapeutic effects of curcumin mediated by JAK/STAT signaling pathway: A review
Milad Ashrafizadeh, Hossein Rafiei, Reza Mohammadinejad, et al.
Phytotherapy Research (2020) Vol. 34, Iss. 8, pp. 1745-1760
Closed Access | Times Cited: 80
The bidirectional role of the JAK2/STAT3 signaling pathway and related mechanisms in cerebral ischemia-reperfusion injury
Yi Zhong, Bo Yin, Yingze Ye, et al.
Experimental Neurology (2021) Vol. 341, pp. 113690-113690
Closed Access | Times Cited: 77
Oncogenic signaling pathways associated with immune evasion and resistance to immune checkpoint inhibitors in cancer
Yoshie Kobayashi, Seung‐Oe Lim, Hirohito Yamaguchi
Seminars in Cancer Biology (2019) Vol. 65, pp. 51-64
Closed Access | Times Cited: 76
Aromatase inhibitors: Role in postmenopausal breast cancer
Rajeev Kharb, Kashif Haider, Kumari Neha, et al.
Archiv der Pharmazie (2020) Vol. 353, Iss. 8
Closed Access | Times Cited: 73
Structural Insights into JAK2 Inhibition by Ruxolitinib, Fedratinib, and Derivatives Thereof
Ryan R. Davis, Baoli Li, Sang Y. Yun, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 4, pp. 2228-2241
Open Access | Times Cited: 73
Accelerating De Novo Drug Design against Novel Proteins Using Deep Learning
Sowmya Ramaswamy Krishnan, Navneet Bung, Gopalakrishnan Bulusu, et al.
Journal of Chemical Information and Modeling (2021) Vol. 61, Iss. 2, pp. 621-630
Closed Access | Times Cited: 70
Insulin/IGF-1 signaling promotes immunosuppression via the STAT3 pathway: impact on the aging process and age-related diseases
Antero Salminen, Kai Kaarniranta, Anu Kauppinen
Inflammation Research (2021) Vol. 70, Iss. 10-12, pp. 1043-1061
Open Access | Times Cited: 65
JAK-STAT in Early Hematopoiesis and Leukemia
Eirini S. Fasouli, Eleni Katsantoni
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 57
Biogenic Phytochemicals Modulating Obesity: From Molecular Mechanism to Preventive and Therapeutic Approaches
Vikram Kumar, Desh Deepak Singh, Sudarshan Singh Lakhawat, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-20
Open Access | Times Cited: 43
Mechanisms of Resistance and Implications for Treatment Strategies in Chronic Myeloid Leukaemia
Govinda Poudel, Molly G. Tolland, Timothy P. Hughes, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3300-3300
Open Access | Times Cited: 38
Momelotinib (JAK1/JAK2/ACVR1 inhibitor): mechanism of action, clinical trial reports, and therapeutic prospects beyond myelofibrosis
Ayalew Tefferi, Animesh Pardanani, Naseema Gangat
Haematologica (2023) Vol. 108, Iss. 11, pp. 2919-2932
Open Access | Times Cited: 36
Clinical course and management of COVID-19 in the era of widespread population immunity
Eric A. Meyerowitz, Jake Scott, Aaron Richterman, et al.
Nature Reviews Microbiology (2023) Vol. 22, Iss. 2, pp. 75-88
Closed Access | Times Cited: 34
Structural basis of Janus kinase trans-activation
Nathanael A. Caveney, Robert A. Saxton, Deepa Waghray, et al.
Cell Reports (2023) Vol. 42, Iss. 3, pp. 112201-112201
Open Access | Times Cited: 28
JAK/STAT Signaling and Cervical Cancer: From the Cell Surface to the Nucleus
Arturo Valle‐Mendiola, Adriana Gutiérrez‐Hoya, Isabel Soto‐Cruz
Genes (2023) Vol. 14, Iss. 6, pp. 1141-1141
Open Access | Times Cited: 27
Exploring the JAK/STAT Signaling Pathway in Hepatocellular Carcinoma: Unraveling Signaling Complexity and Therapeutic Implications
Hyun-Jung Park, S.-H. Lee, Jaehun Lee, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13764-13764
Open Access | Times Cited: 25
Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and solid tumor microenvironment
Yufeng Wang, David L. Drum, Ruochuan Sun, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 24
Ruxolitinib for the treatment of acute and chronic graft-versus-host disease in children: a systematic review and individual patient data meta-analysis
Francesco Baccelli, Francesca Gottardi, Edoardo Muratore, et al.
Bone Marrow Transplantation (2024) Vol. 59, Iss. 6, pp. 765-776
Open Access | Times Cited: 9
Targeting Cellular Trafficking of Fibroblast Growth Factor Receptors as a Strategy for Selective Cancer Treatment
Natalia Porębska, Marta Latko, Marika Kucińska, et al.
Journal of Clinical Medicine (2018) Vol. 8, Iss. 1, pp. 7-7
Open Access | Times Cited: 81
Molecular Characteristics of Uveal Melanoma: Insights from the Cancer Genome Atlas (TCGA) Project
Mathieu F. Bakhoum, Bita Esmaeli
Cancers (2019) Vol. 11, Iss. 8, pp. 1061-1061
Open Access | Times Cited: 70
JAK/STAT signaling in insect innate immunity
In Seok Bang
Entomological Research (2019) Vol. 49, Iss. 8, pp. 339-353
Closed Access | Times Cited: 63
<p>Cannabidiol as a Novel Therapeutic for Immune Modulation</p>
Nadia Peyravian, Sapna K. Deo, Sylvia Daunert, et al.
ImmunoTargets and Therapy (2020) Vol. Volume 9, pp. 131-140
Open Access | Times Cited: 53
JAK/STAT of all trades: linking inflammation with cancer development, tumor progression and therapy resistance
Hatem E. Sabaawy, Bríd M. Ryan, Hossein Khiabanian, et al.
Carcinogenesis (2021) Vol. 42, Iss. 12, pp. 1411-1419
Open Access | Times Cited: 53

Scroll to top